Janux Therapeutics and Bristol Myers Squibb (BMS) are developing a tumor-activated therapeutic in an exclusive licensing agreement.

Gannet BioChem, a specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity ...

Rentschler Biopharma SE has appointed Detra Glinatsis as Head of Business Development U.S., where she will lead all business ...

For the fourth consecutive year, Vetter has been recognized by the internationally renowned EcoVadis sustainability ranking, ...

Cellular Origins and Fresenius Kabi have completed the first phase of a CGT manufacturing collaboration announced in October ...

The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.

Datwyler says it has developed a first-to-market universal plunger for large-volume cartridges containing up to 20mL.

Ember LifeSciences Inc., a provider of cold chain technology, has appointed Ann Hyllengren as Chief Financial Officer to ...

Vetter has earned an EcoVadis Platinum rating and received validation of its emission reduction targets by the Science Based ...

Charles River Laboratories International Inc. and Gazi University Faculty of Medicine have entered a gene therapy CDMO ...

Daiichi Sankyo has expanded its presence in Canada with the official opening of its permanent headquarters in Toronto, ...

Expansion will increase production volume and scale manufacturing capacity for next-gen drugs for metabolic conditions.